Last reviewed · How we verify
NCT05993468
A Pilot Study of a Trauma-Sensitive Mindfulness and Compassion Intervention
trial testing TMC Treatment Approach in Complex Post-Traumatic Stress Disorder in 17 participants. Completed in 1 March 2023.
1 January 2020
Quick facts
| Lead sponsor | Modum Bad |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 17 |
| Start date | 1 January 2019 |
| Primary completion | 1 January 2020 |
| Estimated completion | 1 March 2023 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- TMC Treatment Approach
Conditions studied
- Complex Post-Traumatic Stress Disorder — all drugs for Complex Post-Traumatic Stress Disorder →
Sponsor
Modum Bad
Who can join
Adults 18 to 65, any sex, with Complex Post-Traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This mixed-methods pilot study aim to assess the changes in symptoms of post-traumatic stress disorder (PTSD), complex post-traumatic stress disorder (CPTSD), dissociative symptoms, self-critique, and self-compassion following participation in a 16-week trauma-sensitive mindfulness and compassion (TMC) intervention. Adverse experiences of participation are also explored explicitly.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05993468
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Complex Post-Traumatic Stress Disorder
Currently open trials in the same condition.
- NCT06516874 — A Pilot Study of Trauma-Focused Cognitive-Behavioral Therapy for Treatment of Post-traumatic Stress in Adults. · NA · recruiting
- NCT06464432 — Complex-Posttraumatic Stress Disorder in Urban Egypt: Pilot Testing of a Culturally-adapted Evidence-Based Treatment Man · NA · recruiting
- NCT06233968 — Using Data Science To Center Patient Perspectives in Mechanism Discovery · active not recruiting
- NCT05917613 — Complex-Posttraumatic Stress Disorder - Cultural Adaptation of a Therapeutic Manual and Development of a Culture-specifi · NA · active not recruiting
- NCT06645028 — 8-day Intensive Treatment Programme for PTSD and CPTSD in Sweden · NA · active not recruiting
Other Modum Bad trials
Trials by the same sponsor.
- NCT07432646 — "Finding Solid Ground" in Inpatient Treatment for Dissociative Disorder Patients Followed by Transition to Outpatient Tr · completed
- NCT04444713 — Do Network Centrality Predict Overall Depression Symptom Reduction With Lifting of Social Distancing Protocols? · unknown
- NCT04444115 — Loneliness During Strict and Lifted Social Distancing Protocols Against the COVID-19 Pandemic · unknown
- NCT04365881 — Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology · completed
- NCT03509844 — The Modum Bad Complex Posttraumatic Stress Disorder Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05993468 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Modum Bad
- Last refreshed: 21 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05993468.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing